Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RET (Rearranged during Transfection) receptor tyrosine kinase is a cell surface receptor belonging to the receptor tyrosine kinase (RTK) family, crucial for development and cellular signaling. It comprises an extracellular domain with four cadherin-like repeats for ligand binding, a single transmembrane domain, and an intracellular domain containing a juxtamembrane portion, a split tyrosine kinase domain, and a C-terminal tail (RET9 and RET51 isoforms). RET is activated by GDNF family ligands (GFLs) complexed with GPI-anchored GFRα co-receptors (GFRα1-4). This complex induces RET dimerization and trans-autophosphorylation of specific tyrosine residues, notably Tyr900 and Tyr905 in the activation loop, which stabilizes the active conformation and promotes phosphorylation of other sites, especially in the C-terminus (e.g., Tyr981, Tyr1015, Tyr1062, Tyr1096). Activated RET initiates several downstream pathways including Ras/MAP kinase, PI3 kinase/AKT, and Phospholipase C-γ (PLCγ) by recruiting effectors via phosphorylated tyrosines. Beyond its roles in kidney and nervous system development, neural crest development, and mechanoreceptor differentiation, RET exhibits unique regulatory features: both phosphorylated and nonphosphorylated forms can adopt an active conformation, autophosphorylation has only a modest activity increase, and it lacks an intracellular cis-inhibitory mechanism, suggesting alternative regulatory modes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RET tyrosine kinase receptor (RET).